Adaptive Biotechnologies Q1 Loss Narrows
1/5 23:34
(RTTNews) - Adaptive Biotechnologies Corporation (ADPT), a commercial stage biotechnology company, Thursday reported first-quarter net loss of $29.8 million or $0.20 per share, compared to $47.5 million or $0.33 per share for the same period in 2024....